C-Type Lectin Receptors in Antiviral Immunity and Viral Escape. 2018

Marta Bermejo-Jambrina, and Julia Eder, and Leanne C Helgers, and Nina Hertoghs, and Bernadien M Nijmeijer, and Melissa Stunnenberg, and Teunis B H Geijtenbeek
Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.

C-type lectin receptors (CLRs) are important pattern recognition receptors involved in recognition and induction of adaptive immunity to pathogens. Certain CLRs play an important role in viral infections as they efficiently interact with viruses. However, it has become clear that deadly viruses subvert the function of CLRs to escape antiviral immunity and promote infection. In particular, viruses target CLRs to suppress or modulate type I interferons that play a central role in the innate and adaptive defense against viruses. In this review, we discuss the function of CLRs in binding to enveloped viruses like HIV-1 and Dengue virus, and how uptake and signaling cascades have decisive effects on the outcome of infection.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008247 Lysosomes A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Autolysosome,Autolysosomes,Lysosome
D011951 Receptors, Complement Molecules on the surface of some B-lymphocytes and macrophages, that recognize and combine with the C3b, C3d, C1q, and C4b components of complement. Complement Receptors,Complement Receptor,Complement Receptor Type 1,Receptor, Complement
D002450 Cell Communication Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. Cell Interaction,Cell-to-Cell Interaction,Cell Communications,Cell Interactions,Cell to Cell Interaction,Cell-to-Cell Interactions,Communication, Cell,Communications, Cell,Interaction, Cell,Interaction, Cell-to-Cell,Interactions, Cell,Interactions, Cell-to-Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014777 Virus Diseases A general term for diseases caused by viruses. Viral Diseases,Viral Infections,Virus Infections,Disease, Viral,Disease, Virus,Diseases, Viral,Diseases, Virus,Infection, Viral,Infection, Virus,Infections, Viral,Infections, Virus,Viral Disease,Viral Infection,Virus Disease,Virus Infection
D014780 Viruses Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells. Animal Viruses,Zoophaginae,Animal Virus,Virus,Virus, Animal,Viruses, Animal
D016176 T-Lymphocyte Subsets A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells. T-Cell Subset,T-Cell Subsets,T-Lymphocyte Subset,Subset, T-Cell,Subset, T-Lymphocyte,Subsets, T-Cell,Subsets, T-Lymphocyte,T Cell Subset,T Cell Subsets,T Lymphocyte Subset,T Lymphocyte Subsets

Related Publications

Marta Bermejo-Jambrina, and Julia Eder, and Leanne C Helgers, and Nina Hertoghs, and Bernadien M Nijmeijer, and Melissa Stunnenberg, and Teunis B H Geijtenbeek
March 2017, Viruses,
Marta Bermejo-Jambrina, and Julia Eder, and Leanne C Helgers, and Nina Hertoghs, and Bernadien M Nijmeijer, and Melissa Stunnenberg, and Teunis B H Geijtenbeek
January 2020, Advances in experimental medicine and biology,
Marta Bermejo-Jambrina, and Julia Eder, and Leanne C Helgers, and Nina Hertoghs, and Bernadien M Nijmeijer, and Melissa Stunnenberg, and Teunis B H Geijtenbeek
January 2008, Trends in microbiology,
Marta Bermejo-Jambrina, and Julia Eder, and Leanne C Helgers, and Nina Hertoghs, and Bernadien M Nijmeijer, and Melissa Stunnenberg, and Teunis B H Geijtenbeek
July 2013, Future microbiology,
Marta Bermejo-Jambrina, and Julia Eder, and Leanne C Helgers, and Nina Hertoghs, and Bernadien M Nijmeijer, and Melissa Stunnenberg, and Teunis B H Geijtenbeek
September 2012, Nature immunology,
Marta Bermejo-Jambrina, and Julia Eder, and Leanne C Helgers, and Nina Hertoghs, and Bernadien M Nijmeijer, and Melissa Stunnenberg, and Teunis B H Geijtenbeek
December 2017, Current opinion in microbiology,
Marta Bermejo-Jambrina, and Julia Eder, and Leanne C Helgers, and Nina Hertoghs, and Bernadien M Nijmeijer, and Melissa Stunnenberg, and Teunis B H Geijtenbeek
January 2020, Current topics in microbiology and immunology,
Marta Bermejo-Jambrina, and Julia Eder, and Leanne C Helgers, and Nina Hertoghs, and Bernadien M Nijmeijer, and Melissa Stunnenberg, and Teunis B H Geijtenbeek
June 2017, PLoS pathogens,
Marta Bermejo-Jambrina, and Julia Eder, and Leanne C Helgers, and Nina Hertoghs, and Bernadien M Nijmeijer, and Melissa Stunnenberg, and Teunis B H Geijtenbeek
April 2012, Cytokine,
Marta Bermejo-Jambrina, and Julia Eder, and Leanne C Helgers, and Nina Hertoghs, and Bernadien M Nijmeijer, and Melissa Stunnenberg, and Teunis B H Geijtenbeek
January 2015, Frontiers in immunology,
Copied contents to your clipboard!